Pancreatic Cancer Research

ResearcherUniversity of UtahNo recent work listed

Smitha Krishnamurthi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2411-3504; OpenAlex author ID A5004836221. Sources: ClinicalTrials.gov.

Their work

Papers
4 (first author 1, last author 0)
Trials
2 (principal investigator on 2)
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2007: 1 trial · 2008: 1 trial · 2009: none · 2010: none · 2011: none · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers

Papers 4

  1. Metastatic Pancreatic Cancer: ASCO Guideline Update. Co-author DOI 10.1200/jco.20.01364↗
  2. A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic c… First author PMID 33042633↗
  3. Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update. Co-author DOI 10.1200/jco.2018.78.9636↗
  4. Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study. Co-author DOI 10.1007/s11605-012-2064-6↗

Trials 2

  1. A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreati… Principal investigator NCT01181245↗
  2. Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors Principal investigator NCT00462553↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Davendra P. S. Sohal · 3 shared papers, 2018–2020 · strength 0.25
  2. Alok A. Khorana · 2 shared papers, 2018–2020 · strength 0.16
  3. Eileen Mary O'Reilly · 2 shared papers, 2018–2020 · strength 0.15
  4. Mehmet Sitki Copur · 2 shared papers, 2018–2020 · strength 0.15
  5. Hope Elizabeth Uronis · 2 shared papers, 2018–2020 · strength 0.15
  6. Christopher H. Crane · 2 shared papers, 2018–2020 · strength 0.15
  7. Ignacio Garrido‐Laguna · 2 shared papers, 2018–2020 · strength 0.15
  8. Philip A. Philip · 2 shared papers, 2018–2020 · strength 0.15
  9. Daniel A. Laheru · 2 shared papers, 2018–2020 · strength 0.15
  10. Yogen Saunthararajah · 1 shared paper, 2020 · strength 0.10
  11. Terry H. Landowski · 1 shared paper, 2020 · strength 0.10
  12. Thierry Conroy · 1 shared paper, 2020 · strength 0.09
  13. Pelin Cinar · 1 shared paper, 2020 · strength 0.09
  14. Neeha Zaidi · 1 shared paper, 2020 · strength 0.09
  15. Tyler Paul Johnson · 1 shared paper, 2020 · strength 0.09
  16. Vaibhav Sahai · 1 shared paper, 2020 · strength 0.09
  17. Shubham Pant · 1 shared paper, 2020 · strength 0.09
  18. Ramesh K. Ramanathan · 1 shared paper, 2018 · strength 0.07
  19. Caio Rocha‐Lima · 1 shared paper, 2013 · strength 0.03
  20. Marina Talamonti · 1 shared paper, 2013 · strength 0.03
  21. William C. Small · 1 shared paper, 2013 · strength 0.03
  22. Jeffrey M. Hardacre · 1 shared paper, 2013 · strength 0.03
  23. Howard P. Safran · 1 shared paper, 2013 · strength 0.03
  24. Mary F. Mulcahy · 1 shared paper, 2013 · strength 0.03
  25. Elena Gabriela Chiorean · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.